The University of Debrecen has elevated its level of cooperation with one of the largest global companies specializing in biotechnology to a higher notch in order to provide more efficient services in patient care. The agreement, which was signed on Wednesday, aims, among other things, at supporting the early detection of diseases, the strengthening of appropriate diagnostic pathways and improving patient management in areas that are regarded widespread diseases in Hungary, such as cancer, cardiovascular and chronic respiratory diseases.